Tag: biopharmaceutical
Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings
Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin® line of pain relief products to their marketplace Plantation, Florida, June 8, 2021 — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Luxury Feet™, and Equine Pain-Away™ in the over-the-counter (OTC)
Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers
Plantation, Florida, June 4, 2021 – Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away, Luxury Feet and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today their plans for increasing sales
Professional Snowboarder Jake Vedder Joins Nutra Pharma in Endorsing Nyloxin for Chronic Pain Relief
Nutra Pharma announces that professional snowboarder and wakeboarder, Jake Vedder, is endorsing Nyloxin for Chronic Pain Relief as part of their social media and influencer campaign Plantation, Florida, June 2, 2021 — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain
PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market
Sandusky, OH, May 27, 2021 – McapMediaWire — PAO Group, Inc. (OTC Pink: PAOG) today highlighted Alkame Holdings, Inc’s (OTC Pink: ALKM) recent news reporting the near completion status of its new production facility: ALKM – Alkame Confirms $15 Million Annual Revenue Bottling Production Potential PAOG recenlty released a preview of the company’s plan
Nutra Pharma Provides Updates on Improvements of Manufacturing Capabilities
Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for the production of their over-the-counter pain relievers Plantation, Florida, May 27, 2021 — McapMediaWire — Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away™, Equine Pain-Away™ and Luxury Feet™ in the over-the-counter (OTC) pain management
PAOG Targets International Segment Of $5 Billion CBD Nutraceutical Market
Sandusky, OH, May 13, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products. The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion
PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday
Sandusky, OH, May 5, 2021 – OTC PR WIRE — PAO Group, Inc. (USOTC: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived
PAOG CBD Nutraceuticals To Hit Market This Year
Sandusky, OH, May 4, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive
PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday
Sandusky, OH, May 3, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive
PAOG Anticipates Boost To CBD Pharmaceutical Research Initiative From Improving Cannabis Legalization Outlook
Sandusky, OH, April 28, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG’s ongoing CBD Pharmaceutical Development Program. PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmaceutical grade indoor hemp grow facility and CBD extraction facility in
Recent Posts
Archives
Categories
- Aerospace
- Agriculture
- Aircraft
- Alternative Energy
- ALYI
- Apparel
- Applications
- Arts
- AUTOMOTIVE
- Autoparts
- Banking
- Barchart
- Basketball
- Beauty Products
- Benzinga
- Beverage
- Biotechnology
- Bitcoin
- Blockchain
- Branding
- Building Material
- CANNABIS
- CBD
- Cloud
- Coffee
- Communication
- Construction
- Consumer
- Corporate
- COVID_19
- COVID-19
- Crew Management
- CRM
- Cryptocurrency
- CSE
- Digital
- Digital Currency
- ECommerce
- EDM MEDIA
- EIN Newswire
- Electric Vehicles
- Energy
- Entertainment
- Environment
- Events
- Export
- Fashion
- Featured
- Film
- Financial
- Fintech
- Fitness
- Fleet Management
- Food
- Food for thought
- Frozen Food
- Ftiness
- Fuel
- GALENFEHA
- Gaming
- GEGR
- Gold
- Government
- GPS Tracking
- Healthcare
- HEMP
- ICO
- IMTL
- INSIDER FINANCIAL
- Insurance
- Internet
- Investingcom
- Investment
- Investor Relations
- IoT
- Jewelry
- Lifestyle
- Logistic
- Luxery Goods
- Manufacturing
- Marijuana
- Marketing
- Media
- Medical
- Merger & Acquisition
- Mining
- Moodys
- Motorcycle
- NASDAQ
- Network
- Newsroom
- NFT
- Nutrition
- NYSE
- Oil & Gas
- Online
- OTC Markets
- OTCQB
- OTT
- PAOG
- Pet
- Pharmaceutical
- Precious Metals
- Psychedelic Mushroom
- Public Relations
- Publicity
- QMedia
- Quote
- Rare Earth
- Real Estate
- Renewable Energy
- Renovable Energy
- Rental
- Retail
- RF Components
- RLTR
- SaaS
- Science
- Security
- SFIN
- Shareholders
- Shipping
- Skincare
- Social Media
- Software
- Solar Energy
- Spirits
- Sports
- SSET
- Staffing
- Streaming
- Supplements
- Tech
- Telecommunication
- Television
- Tequila
- Transportation
- UCIX
- Uncategorized
- Video Post
- VR
- Waste Treatment
- Water Treatment
- Wellness
- Wind Power
Contact Us
- 707-OTC-WIRE (707-682-9473)
- cs@otcprwire.com
Recent Comments